New Aspirin SCAM? Don’t Fall For It

It’s the Holy Grail of pharmaceutical drugs—not a drug that can cure you, but a drug that you’ll have to take for the rest of your life.

That’s called residual income, and money-grubbing Big Pharma execs love it.

And it doesn’t get much more residual than “an aspirin a day.”

They’ve already got millions of people with heart disease taking it to prevent heart attacks—and you’ll never guess what they’re claiming it can prevent now.

But don’t fall for it—because a study has proven that it DOESN’T WORK.

People have been conned into taking an aspirin for primary prevention of a heart attack for years.

And because aspirin thins the blood and reduces inflammation, researchers thought (read: hoped) it could help reduce the risk of dementia as well.

But they were wrong.

In a study of over 19,000 people mostly over 70 years old, half were given 100 mg of aspirin a day, while the other half got a placebo.

They took multiple thinking and memory tests over the course of the 4-year study to see if aspirin could delay or prevent the development of mild cognitive impairment or dementia.

And do you know what the researchers found?

You guessed it!

Aspirin didn’t do a darned thing to prevent dementia.

The only time I would take aspirin was if I was in the middle of having a heart attack—and that’s what I recommend for my patients as well.

The benefits are too small—and the risks too great—to be taking the stuff on a regular basis.

If you could take a pill that was guaranteed to prevent dementia, I’m sure you would.

Heck, I might even take one just to be on the safe side.

But that kind of pill doesn’t exist—no matter what Big Pharma says.